Aphea.Bio Series A

Investor-issued announcement separates EUR 7.7m equity from EUR 1.3m non-dilutive capital; headline EUR 9m is not the equity round.

EUR 7,700,000 AmountJun 26, 2017 Announced

Source evidence

V-Bio Ventures
Active Belgian life sciences VC investing in biotech and drug development companies.

Something wrong or missing? Send an update. Fixed within 24 hours.